Systemic antifungal therapy for tinea capitis in children

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2007, Pages

  González, Urbà ^a   Seaton, T ^b   Bergus, G ^b   Jacobson, J ^b   Martinez Monzon C ^b  

^a HOSPITAL PLATÓ   (Spain)

^b NONE

Author keywords

Antifungal agents *therapeutic use ; Child; Fluconazole therapeutic use ; Griseofulvin therapeutic use ; Itraconazole therapeutic use ; Naphthalenes therapeutic use ; Randomized controlled trials as topic; Tinea capitis *drug therapy

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; PLACEBO; SELENIUM SULFIDE; TERBINAFINE;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; APPETITE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY ACHE; CHILD CARE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; COUGHING; DERMATOPHYTE; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPEPSIA; EOSINOPHILIA; EPISTAXIS; FACIAL SWELLING; FATIGUE; FEVER; FLU LIKE SYNDROME; FOLLOW UP; FUNGUS CULTURE; GASTROENTERITIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; IMMUNITY; LABIAL EDEMA; LEUKOCYTOSIS; LIVER DISEASE; LIVER DYSFUNCTION; MICROSCOPY; MICROSPORUM; MICROSPORUM AUDOUINII; MICROSPORUM CANIS; MICROSPORUM FERUGINEUM; MOUTH DISEASE; NAUSEA; NEUTROPENIA; PAIN; PARASITOSIS; PATHOGENESIS; PATIENT COMPLIANCE; PHARYNGITIS; PRURITUS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCORING SYSTEM; SIDE EFFECT; SKIN DISEASE; SKIN SCALING; SOMNOLENCE; STOMACH DISEASE; STOMACH PAIN; SWELLING; TASTE DISORDER; TINEA CAPITIS; TREATMENT DURATION; TREATMENT OUTCOME; TRICHOPHYTON; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON SCHOENLEINI; TRICHOPHYTON TONSURANS; TRICHOPHYTON VERRUCOSUM; TRICHOPHYTON VIOLACEUM; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; URTICARIA; VERTIGO; VIRUS INFECTION; VOMITING; WEIGHT REDUCTION;

EID: 44949140724     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004685.pub2     Document Type: Review

References (47)

1. Cáceres-Ríos 2000 {published data only} *Cáceres-Ríos H, Rueda M, Ballona R, Bustamante B. Comparison of terbinafine and griseofulvin in the Treatment of tinea capitis. Journal of the American Academy of Dermatology 2000;42(1Pt 1):80-4.
2. Cáceres- Ríos h, Rueda M, Ballona R, Mostajo F, Kumakawa H, Bustamante B. Comparison of terbinafine and griseofulvin in the Treatment of Tinea Capitis. Annales de Dermatologie et de Venereologie 1998;125 Suppl 1:1s21 (Abs.015).
3. Dastghaib 2005 {published data only} *Dastghaib L, Azizzadeh M, Jafari P. Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole. Journal of Dermatological Treatment 2005;16:43-6.
4. Friedlander 2002 {published data only} *Friedlander SF, Aly R, Krafchik B, Blumer J, Honig P, Stewart D, et al.Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study. Pediatrics 2002;109(4): 602-7.
5. Fuller 2001 {published data only} *Fuller LC, Smith CH, Cerio R, Marsden RA, Midgley G, Beard AL, et al.A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis. British Journal of Dermatology 2001;144:321-7.
6. Gan 1987 {published data only} *Gan VN, Petruska M, Ginsburg CM. Epidemiology and treatment of tinea capitis: ketoconazole vs. griseofulvin. The Pediatric Infectious Disease Journal 1987;6(1):46-9.
7. Gupta 2001 {published data only} *Gupta KA, Adam P, Dlova N, Lynde CW, Hofstader S, Morar N, et al.Therapeutic options for the treatment of tinea capitis caused by trichophyton species: Griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatric Dermatology 2001;18(5):433-8.
8. Hamm 1999 {published data only} *Hamm H, Schwinn A, Bräutigam M, Weidinger G and the Study Group. Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species. British Journal of Dermatology 1999;140:480-2.
9. Schwinn A, Hamm H, Bräutigam M, Weidinger G, Williams T. What is the best approach to tinea capitis with terbinafine. Journal of the European Academy of Dermatology and Venereology 1998;11(Suppl.2):s232.
10. Schwinn A, Hamm H, Bräutigam M, Weidinger G, Williams T. What is the best approach to tinea capitis with terbinafine?. Annales de Dermatologie et de Venereologie 1998;125(suppl.1):1s133-1s134 (Abs.p147).
11. Haroon 1995 {published data only} Alvi KH, Iqbal N, Khan KA, Haroon TS, Hussain I, Aman S, et al.A randomized, double blind trial of the efficacy and tolerability of terbinafine once daily compared to griseofulvin once daily in the treatment of tinea capitis. In: ShusterS, JafaryMH editor(s). Royal Society of Medicine Services International Congress Series. Vol. 205, London: Royal Society of Medicine Press Ltd, 1992:35-40.
12. Haroon TS, Hussain I, Aman S, Jahangir M, Kazmi AH, Sami AR, et al.Randomized double-blind multicentre study of efficacy and tolerability of terbinafine for 1, 2, and 4 weeks in the treatment of tinea capitis. Journal of the European Academy of Dermatology and Venereology 1995;5(suppl 1):s79-s80.
13. *Haroon TS, Hussain I, Aman S, Nagi AH, Ahmad I, Zahid M, et al.A randomized double-blind comparative study of terbinafine and griseofulvin in tinea capitis. Journal of Dermatological Treatment 1995;6:167-9.
14. Haroon 1996 {published data only} *Haroon TS, Hussain I, Aman S, Jahangir M, Kazmi AH, Sami AR, et al.A randomized double-blind comparative study of terbinafine for 1, 2, and 4 weeks in tinea capitis. Br J Dermatol 1996;135(1):86-8.
15. Jahangir 1998 {published data only} *Jahangir M, Hussain I, Ul Hassan M, Haroon TS. A double-blind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis. British Journal of Dermatology 1998;139:672-4.
16. Kullavanijaya 1997 {published data only} *Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis [comment in Journal of the American Academy of Dermatol 1998; 39(1):136]. Journal of the American Academy of Dermatology 1997;37(2 Pt 1):272-3.
17. Lipozencic 2002 {published data only} *Lipozencic J, Skerlev M, Orofino-Costa R, Zaitz VC, Horvath A, Chouela E, et al.A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. British Journal of Dermatology 2002;146(5): 816-23.
18. López-Gómez 1994 {published data only} *López-Gómez S, Del Palacio A, Van Cutsem J, Cuétara MS, Iglesias L, Ródriguez Noriega A. Itraconazole versus griseofulvin in the treatment of tinea capitis: A double-blind randomized study in children [comment in the International Journal of Dermatology 1994;33(10):701. International Journal of Dermatology 1994;33(10):743-7.
19. Martínez-Roig 1988 {published data only} *Martínez-Roig A, Torres-Rodríguez JM, Bartlettcoma A. Double blind study of ketoconazole and griseofulvin in dermatophytoses. The Pediatric Infectious Disease Journal 1988;7(1):37-40.
20. Memisoglu 1999 {published data only} *Memisoglu HR, Erboz S, Akkaya S, Akan T, Aksungur VL, Ünal I, et al.Comparative study of the efficacy and tolerability of 4 weeks of terbinafine therapy with 8 weeks of griseofulvin therapy in children with tinea capitis. Journal of Dermatological Treatment 1999;10:189-93.
21. Rademaker 1998 {published data only} *Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children. New Zealand Medical Journal 1998;111(1060):55-7.
22. Solomon 1997 {published data only} *Solomon BA, Collins R, Sharma R, Silverberg N, Jain AR, Sedgh J, et al.Fluconazole for the treatment of tinea capitis in children. Journal of the American Academy of Dermatology 1997;37(2 Pt 1):274-5.
23. Talarico Filho 1998 {published data only} *Talarico Filho T, Cucé LC, Foss NT, MArques SA, Santamaria JR. Efficacy, safety and tolerability of terbinafine for tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1, 2 and 4 weeks. Journal of the European Academy of Dermatology & Venereology 1998;11(2):141- 6.
24. Tanz 1985 {published data only} *Tanz RR, Stagl S, Burton Esterly N. Comparison of ketoconazole and griseofulvin for treatment of tinea capitis in childhood: A preliminary study. Pediatric Emergency Care 1985;1(1):16-8.
25. Tanz 1988 {published data only} *Tanz RR, Hebert AA, Burton Esterly N. Treating tinea capitis: Should ketoconazole replace griseofulvin?. Journal of Pedriatics 1988;112(6):987-91.
26. Ungpakorn 2004 {published data only} *Ungpakorn R, Ayutyanont T, Reangchainam S, Supanya S. Treatment of Microsporum spp. tinea capitis with pulsed oral terbinafine. Clinical and Experimental Dermatology 2004;29:300-3.
27. Ginsburg 1987 Ginsburg C, Ghan NV, Petruska M. Randomized controlled trial of intralesional corticosteroid and griseofulvin vs. griseofulvin alone for treatment of kerion. The Pediatric Infectious Disease Journal 1987;6(12):1084-7.
28. Honig 1994 Honig PJ, Caputo GL, Leyden JJ, McGinley K, Selbst SM, McGravey AR. Treatment of kerions. Pediatric Dermatology 1994;11:69-71.
29. Hussain 1999 Hussain I, Muzaffar F, Rashid T, Ahmad TJ, Jahangir M, Haroon TS. A randomized, comparative trial of treatment of kerion celsi with griseofulvin plus oral prednisolone vs. Griseofulvin alone. Medical Mycology 1999;37:97-9.
30. Foster 2005 Foster KW, Friedlander SF, Panzer H, Ghannoum MA, Elewski BE. A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis. Journal of the American Academy of Dermatology 2005;53(5):798-809.
31. Pather 2006 Pather S. Aprospective, randomized, single-blinded trial to determine the efficacy of single and weekly dose regimens of oral griseofulvin versus 6 weeks of daily dosing in the treatment of tinea capitis in children. British Journal of Dermatology. 2006; Vol. 155 (Suppl. 1):106-19.
32. Aly 1999 Aly R. Ecology, epidemiology and diagnosis of tinea capitis. The Pediatric Infectious Diseases Journal 1999;18:180-5.
33. Aste 2004 Aste N, Pau M. Tinea capitis caused by Microsporum canis treated with terbinafine. Mycoses 2004;47(9-10):428-30.
34. Bennet 2000 Bennet ML, Fleischer AB, Loveless JW, Feldman. Oral griseofulvin remains the treatment of choice for tinea capitis in children. Pediatric Dermatology 2000;17:304-9.
35. Blumer 1999 Blumer JL. Pharmacologic basis for the treatment of tinea capitis. The Pediatric Infectious Disease Journal 1999;18:191-9.
36. Commens 2003 Commens C. Which drug is most effective in treating childhood tinea capitis caused by Microsporum species?. The Medical Journal of Australia 2003;178(11):577-8.
37. Devliotou 2004 Devliotou-Panagiotidou D, Koussidou-Eremondi TH. Efficacy and tolerability of 8 weeks' treatment with terbinafine in children with tinea capitis caused by Microsporum canis: a comparison of three doses. Journal of the European Academy of Dermatology & Venereology 2004;18(2):155-9.
38. Elewski 2000 Elewski BE. Tinea capitis: a current perspective. Journal of the American Academy of Dermatology 2000;42:1-24.
39. Fleece 2004 Fleece D, Guaghan JP, Stephen C, Aronoff C. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials. Pediatrics 2004;114(5):1312-5.
40. Friedlander 2000 Friedlander SF. The optimal therapy for tinea capitis. Pediatric Dermatology 2000;17:325-6.
41. Fuller 2003 Fuller LC, Child FJ, Midgley G, Higgins EM. Diagnosis and management of scalp ringworm. BMJ 2003;326:539-41.
42. Ginter 2004 Ginter-Hanselmayer G, Smolle J, Gupta A. Itraconazole in the treatment of tinea capitis caused by Microsporum canis: experience in a large cohort. Pediatric Dermatology 2004;21(4):499-502.
43. González 2003 González U. Tinea capitis. In: WilliamsH, BigbyM, DiepgenT, HerxeimerA, NaldiL, RzanyB editor(s). Evidence-based Dermatology. London: BMJ Books, 2003:469-89.
44. Gupta 1999 Gupta AK, Hofstader SLR, Adam P. Tinea capitis: An overview with emphasis on management. Pediatric Dermatology 1999;16:171-89.
45. Higgins 2000 Higgins EM, Fuller LC, Smith CH. Guidelines for the management of tinea capitis. British Journal of Dermatology 2000;143:53-8.
46. Juni 2001 Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled trials. British Medical Journal 2001;323:42-6.
47. Möhrenschlager 2005 Móhrenschlager M, Seidl HP, Ring J, Abeck D. Pediatric tinea capitis. Recognition and management. American Journal of Clinical Dermatology 2005;6:203-13.